Assembly Biosciences (ASMB) Change in Account Payables (2014 - 2026)
Assembly Biosciences' (ASMB) quarterly Change in Account Payables came in at -$42000.0 in Q1 2026, down 114.48% year-on-year from $290000.0 in Q1 2025, and up 91.8% quarter-over-quarter from -$512000.0 in Q4 2025.
Assembly Biosciences (ASMB) Change in Account Payables (2014 - 2026) Analysis & Trends
Assembly Biosciences' Change in Account Payables history runs 13 years deep, the most recent figure standing at -$42000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 114.48% year-over-year to -$42000.0 in Q1 2026; TTM through Mar 2026 was $254000.0, a 71.62% increase from a year earlier, with the FY2025 full-year figure at $586000.0, up 372.58% from the prior year.
- Change in Account Payables improved to -$42000.0 in Q1 2026 per ASMB's latest filing, from -$512000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.0 million in Q2 2022 and bottomed at -$1.3 million in Q1 2023.
- The 5-year median for Change in Account Payables is -$132000.0 (2025), against an average of -$90000.0.
- Across the five-year window, Change in Account Payables soared 1677.42% in 2022 and plunged 278.38% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $551000.0 in 2022, then plunged by 153.9% to -$297000.0 in 2023, then plunged by 152.53% to -$750000.0 in 2024, then surged by 31.73% to -$512000.0 in 2025, then jumped by 91.8% to -$42000.0 in 2026.
- Per Business Quant, the three latest ASMB Change in Account Payables figures stand at -$42000.0 (Q1 2026), -$512000.0 (Q4 2025), and $940000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Assembly Biosciences | 282.74 Mn | 56.14 Mn | - | -42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,000.00 |
| Mar 31, 2026 | -42,000.00 |
| Dec 31, 2025 | -512,000.00 |
| Dec 31, 2025 | -512,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Dec 31, 2024 | -750,000.00 |
| Dec 31, 2024 | -750,000.00 |
| Sep 30, 2024 | 534,000.00 |
| Sep 30, 2024 | 534,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Dec 31, 2023 | -297,000.00 |
| Dec 31, 2023 | -297,000.00 |